SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-298016
Filing Date
2021-10-14
Accepted
2021-10-13 18:54:32
Documents
1
Group Members
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.VIFOR PHARMA LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d217397dsc13da.htm SC 13D/A 72613
  Complete submission text file 0001193125-21-298016.txt   74183
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Subject) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86723 | Film No.: 211322145
SIC: 2834 Pharmaceutical Preparations

Mailing Address RECHENSTRASSE 37 ST. GALLEN V8 9000
Business Address RECHENSTRASSE 37 ST. GALLEN V8 9000 41 58 851 80 00
Vifor (International) Ltd (Filed by) CIK: 0001675217 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A